A meta-analysis similarly indicated that for each doubling of CRP concentration, risk of any breast cancer and postmenopausal breast cancer was elevated 7% (95% CI 2–12%) and 6% (95% CI 1–11%), respectively [51]. The gene discussed is CRP; the disease is breast carcinoma.